Skip to main content
Top

Current Treatment Options in Oncology

Issue 11/2018

Content (9 Articles)

Lung Cancer (HA Wakelee, Section Editor)

Targeted Therapy and Immune Therapy for Small Cell Lung Cancer

Shirish M. Gadgeel

Lung Cancer (HA Wakelee, Section Editor)

Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer

Herbert H. Loong, Sui-chun Sampson Kwan, Tony Shu-kam Mok, Yat-ming Lau

Lymphoma (DO Persky, Section Editor)

Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma

Roopesh Kansara

Gynecologic Cancers (LA Cantrell, Section Editor)

Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions

Rachel N. Grisham, Gopa Iyer

Open Access Skin Cancer (T Ito, Section Editor)

Dermatoscopy of Neoplastic Skin Lesions: Recent Advances, Updates, and Revisions

Philipp Weber, Philipp Tschandl, Christoph Sinz, Harald Kittler

Skin Cancer (T Ito, Section Editor)

Immunotherapy for Merkel Cell Carcinoma

Kotaro Nagase, Yutaka Narisawa

Skin Cancer (T Ito, Section Editor)

Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

Sabran J. Masoud, Jennifer A. Perone, Norma E. Farrow, Paul J. Mosca, Douglas S. Tyler, Georgia M. Beasley

Neuro-oncology (GJ Lesser, Section Editor)

Immunotherapy for Brain Tumors

Lan B. Hoang-Minh, Duane A. Mitchell

Head and Neck Cancer (L Licitra, Section Editor)

Head and Neck Cancer: Improving Patient-Reported Outcome Measures for Clinical Practice

Augusta Silveira, Eurico Monteiro, Teresa Sequeira

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine